ARCHIVES

FDA Delays Decision On Avastin Approval For Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 34 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

June 28, 2013

NCI-Funded Modelers Accurately Predicted Outcome Of Lung Cancer Screening Trial

November 26, 2010

Rauscher Labels With Congress, Says NCI Needs More Money

May 2, 1975

Funding Opportunities.

April 5, 2002

International Group Plans Survey On Thrombosis Risk

July 27, 2001

Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA

May 23, 1986